Browsing: Selected

Last week, the U.S. Food and Drug Administration (FDA) announced the inaugural manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. The manufacturer, Dexcom, Inc., a company that develops a line of continuous glucose monitoring systems, plans to offer a device to support care expected to be covered by the…